mesa20141002_8k.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549   

 

FORM 8-K

 


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

OCTOBER 2, 2014
Date of Report (Date of earliest event reported)

 

MESA LABORATORIES, INC.
(Exact name of registrant as specified in its charter)

 

Commission File Number: 0-11740

 

COLORADO
(State or other jurisdiction of
incorporation)

 

84-0872291
(I.R.S. Employer
Identification No.)


 

12100 WEST SIXTH AVENUE,

LAKEWOOD, COLORADO
(Address of principal executive offices)

 

  80228
(Zip Code)

 

Registrant’s telephone number, including area code: (303) 987-8000

 

Not Applicable
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

|_|

  

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

|_|

  

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

|_|

  

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

|_|

  

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 



 
 

 

 

ITEM 5.07

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

The Annual Meeting of Shareholders of Mesa Laboratories, Inc. was held on October 2, 2014. Of the 3,509,273 shares of common stock entitled to vote, 3,147,740 were represented either in person or proxy. Seven directors were elected to serve until the next Annual Meeting of Shareholders. The advisory vote to approve executive compensation was approved. The Mesa Laboratories, Inc. 2014 Equity Plan was approved. The ratification of the appointment of EKS&H LLLP as the Company’s independent registered public accounting firm for the year ending March 31, 2015 was approved.

 

The seven directors elected were:

 

   

 

               Broker  

 

 

For

   

Withheld

       Non-Votes  

Luke R. Schmieder

    2,116,838       554,035       476,867  

John J. Sullivan, Ph.D.

    2,657,245       13,628       476,867  

Michael T. Brooks

    2,651,891       18,982       476,867  

H. Stuart Campbell

    2,609,670       61,203       476,867  

Robert V. Dwyer

    1,851,821       819,052       476,867  

Evan C. Guillemin

    2,655,731       15,142       476,867  

David M. Kelly

    2,652,613       18,260       476,867  

 

The advisory vote to approve executive compensation was approved by the following vote:

 

                        Broker  

For

   

Against

   

Abstain

   

Non-Votes

 
  2,566,144       32,980       71,749       476,867  

 

The Mesa Laboratories, Inc. 2014 Equity Plan was approved by the following vote:

 

                        Broker  

For

   

Against

   

Abstain

   

Non-Votes

 
  2,163,107       464,040       43,726       476,867  

 

The appointment of EKS&H LLLP as the Company’s independent registered public accounting firm for the year ending March 31, 2015 was approved by the following vote:

 

                        Broker  

For

   

Against

   

Abstain

   

Non-Votes

 
  3,137,630       9,574       536       --  

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

DATE: October 2, 2014

 

Mesa Laboratories, Inc.

 

 

 

         (Registrant)

 

       
       

 

BY:

/s/ John J. Sullivan

 

 

 

John J. Sullivan,

 

 

 

President and Chief Executive Officer